FDA Panel Recommends Approving First Peanut Allergy Treatment – The Washington Post

Read article - Quotes Marcus Shaker, associate professor of pediatrics and associate professor of community and family medicine, in an article about how advisers to the Food and Drug Administration voted Friday to recommend approval of a first-of-its-kind peanut allergy treatment. "For a family with high anxiety and a significant burden of anxiety and fear from living with [a] peanut allergy, this might give that extra buffer of safety," says Shaker, who was not involved with the trial. "They're still going to need to strictly avoid peanuts, but [this will help] to let go of some of the fear they may have." (Picked up by PennLive.)